Supplementation Of ͢-Sitosterol
Subarachnoid Haemorrhagic Stroke
Second Affiliated Hospital, School of Medicine, Zhejiang UniversitySmall moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Subarachnoid Haemorrhagic Stroke cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
PROPOFOL Azienda Ospedaliera San Gerardo di Monza | Phase 4 | BB |
ISOFLURANE Azienda Ospedaliera San Gerardo di Monza | Phase 4 | BB |
DICLOFENAC Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Phase 4 | BB |
Dabigatran University of Edinburgh | Phase 3 | BB |
Rivaroxaban University of Edinburgh | Phase 3 | BB |
View all 24 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →